EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 22 / Numéro 12 (Décembre 2006) Med Sci (Paris), 22 12 (2006) 1095-1100 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 22, Numéro 12, Décembre 2006
Page(s) 1095 - 1100
Section M/S revues
DOI https://doi.org/10.1051/medsci/200622121095
Publié en ligne 15 décembre 2006
  1. Brown AJ, Dusso AS, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277 : F157–75. [Google Scholar]
  2. Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101 : 7711–5. [Google Scholar]
  3. Souidi M, Dubrac S, Parquet M, Lutton C. Hepatic and extrahepatic sterol 27-hydroxylase: roles in cholesterol and bile acid metabolism and associated diseases. Gastroenterol Clin Biol 2003; 27 : 100–11. [Google Scholar]
  4. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29 : 664–73. [Google Scholar]
  5. Nykjaer A, Dragun D, Walther D, et al. endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 Cell 1999; 96 : 507–15. [Google Scholar]
  6. Leheste JR, Melsen F, Wellner M, et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 2003; 17 : 247–9. [Google Scholar]
  7. Garabédian M. La 1,25dihyroxyvitamine D et son récepteur. Rev Rhum 2000; 67 (suppl 2) : 39–41. [Google Scholar]
  8. Miller WL, Portale AA. Vitamin D 1 alpha hydroxylase. Trends Endocrinol Metab 2000; 11 : 315–9. [Google Scholar]
  9. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13 : 100–5. [Google Scholar]
  10. Schuessler M, Astecker N, Herzig G, et al. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases. Steroids 2001; 66 : 399–408. [Google Scholar]
  11. Post SM, Duez H, Gervois PP, et al. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 2001; 21 : 1840–5. [Google Scholar]
  12. Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 2003; 313 : 71–82. [Google Scholar]
  13. Quinn CM, Jessup W, Wong J, et al. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem J 2005; 385 : 823–30. [Google Scholar]
  14. Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005; 433 : 397–412. [Google Scholar]
  15. Armbrecht HJ, Hodam TL, Boltz MA. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Arch Biochem Biophys 2003; 409 : 298–304. [Google Scholar]
  16. Hewison M, Zehnder D, Bland R, Stewart PM. 1α-Hydroxylase and the action of vitamin D. Mol Endocrinol 2000; 25 : 141–8. [Google Scholar]
  17. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004; 65 : 1–14. [Google Scholar]
  18. Gao XH, Dwivedi PP, Omdahl JL, et al. Calcitonin stimulates expression of the rat 25-hydroxyvitamin D3-24-hydroxylase (CYP24) promoter in HEK-293 cells expressing calcitonin receptor: identification of signaling pathways. J Mol Endocrinol 2004; 32 : 87–98. [Google Scholar]
  19. Chen KS, DeLuca HF. Cloning of the human 1 alpha, 25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochem Biophys Acta 1995; 1263 :1–9. [Google Scholar]
  20. Murayama A, Kim M, Yanagisawa J, et al. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 2004; 23 : 1598–608. [Google Scholar]
  21. Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115 : 177–86. [Google Scholar]
  22. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289 : F8–28. [Google Scholar]
  23. Norman AW, Ishizuka S, Okamura WH. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 2001; 76 : 49–59. [Google Scholar]
  24. Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3 : Basic concepts. J Steroid Biochem Mol Biol 2005; 97 : 93–101. [Google Scholar]
  25. Holick MF. Vitamin D : A millenium perspective. J Cell Biochem 2003; 88 : 296–307. [Google Scholar]
  26. Holick MF. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 1995; 17 (suppl 2) : S107–11. [Google Scholar]
  27. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2 : 1017–28. [Google Scholar]
  28. St-Arnaud R, Glorieux FH. 24, 25-Dihydroxyvitamin D: active metabolite or inactive catabolite ? Endocrinology 1998; 139 : 3371–4. [Google Scholar]
  29. Garabédian M, Menn S, Walrant-Debray O, et al. Prevention of child and adolescent vitamin D deficiency. II. Validation of a decision-making abacus based on sun exposure and vitamin D intakes. Arch Pediatr 2005; 12 : 410–9. [Google Scholar]
  30. Maugars Y, Glémarec J, Guillot P, et al. Métabolisme phosphocalcique et ostéomalacie. Rev Rhum 2000; 67 (suppl 2) : 95–8. [Google Scholar]
  31. Breuil V, Euller-Ziegler. Nutrition et vieillissement osseux : l’ostéoporose. Nutr Clin Metab 2004; 18 : 212–8. [Google Scholar]
  32. Gascon-Barré M. Antiepileptic drugs and bone health. In : Dawson-Hughes B, Holick MF, eds. Nutrition and bone health. Totowa-New Jersey, USA : Humana Press, 2004 : 647–66. [Google Scholar]
  33. Pascussi JM, Vilarem MJ. Ostéomalacie consécutive à la prise prolongée de médicaments. Sur la piste de PXR, un récepteur impliqué dans la détoxication. Med Sci (Paris) 2005; 21 : 582–3. [Google Scholar]
  34. Kato S, Yoshizazawa T, Kitanaka S, et al. Molecular genetics of vitamin D- dependent hereditary rickets. Horm Res 2002; 57 : 73–8. [Google Scholar]
  35. Dumas R. Les rachitismes vitaminorésistants. Arch Pediatr 1999; 6 : 715–9. [Google Scholar]
  36. Souberbielle JC, Friedlander G, Kahan A, Cormier C. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73 : 249–53. [Google Scholar]
  37. Holick MF. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes 1995; 103 : 219–27. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.